The store will not work correctly when cookies are disabled.
1-[2-(4-Chloro-phenyl)-2-oxo-ethyl]-1H-indole-2,3-dione
ID: ALA83686
Cas Number: 75822-38-7
PubChem CID: 2247580
Max Phase: Preclinical
Molecular Formula: C16H10ClNO3
Molecular Weight: 299.71
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CN1C(=O)C(=O)c2ccccc21)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C16H10ClNO3/c17-11-7-5-10(6-8-11)14(19)9-18-13-4-2-1-3-12(13)15(20)16(18)21/h1-8H,9H2
Standard InChI Key: XZZXOUNMODASMA-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
4.8292 -7.3125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.3125 -6.6417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8167 -5.9750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0417 -7.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0375 -6.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0875 -8.0917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8792 -8.3042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1375 -6.6375 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0667 -5.1917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.2875 -9.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3792 -7.6500 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.8667 -9.7250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1042 -9.0167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1000 -10.4417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -5.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2750 -10.4375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5042 -9.7375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5042 -11.1542 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -7.4792 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6042 -6.2417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6042 -7.0667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 1 1 0
5 4 1 0
6 1 1 0
7 6 1 0
8 2 2 0
9 3 2 0
10 7 1 0
11 7 2 0
12 10 1 0
13 10 2 0
14 17 2 0
15 5 2 0
16 12 2 0
17 13 1 0
18 14 1 0
19 4 2 0
20 21 2 0
21 19 1 0
3 5 1 0
15 20 1 0
16 14 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 299.71 | Molecular Weight (Monoisotopic): 299.0349 | AlogP: 2.75 | #Rotatable Bonds: 3 |
Polar Surface Area: 54.45 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 2.65 | CX LogD: 2.65 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.65 | Np Likeness Score: -1.09 |
References
1. Shuttleworth SJ, Nasturica D, Gervais C, Siddiqui MA, Rando RF, Lee N.. (2000) Parallel synthesis of isatin-based serine protease inhibitors., 10 (22): [PMID:11086715] [10.1016/s0960-894x(00)00523-0] |
2. PubChem BioAssay data set, |